Passage Bio Inc (PASG) — Net Asset Momentum
Passage Bio Inc (PASG) recorded a net asset momentum of -69.4% as of December 2025, with net assets of $18.75 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. For live market cap and overall valuation, see how much is Passage Bio Inc worth.
YoY Momentum
Current Net Assets
Years of Data
Country
Passage Bio Inc Net Asset Momentum (2018–2025)
This chart tracks Passage Bio Inc's year-over-year net asset growth across 8 annual reporting periods from 2018 to 2025. The most recent momentum reading is -69.4%, with net assets of $18.75 Million USD as of December 2025. Check PASG PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Net Asset History for Passage Bio Inc (2018–2025)
The table below shows the complete annual net asset history for Passage Bio Inc from 2018 to 2025, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check tangible equity quality of Passage Bio Inc to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $18.75 Million | $62.28 Million | $43.53 Million | ▼ -69.4% |
| 2024 | $61.26 Million | $102.41 Million | $41.15 Million | ▼ -45.0% |
| 2023 | $111.28 Million | $150.54 Million | $39.26 Million | ▼ -44.7% |
| 2022 | $201.37 Million | $243.55 Million | $42.18 Million | ▼ -36.8% |
| 2021 | $318.66 Million | $355.08 Million | $36.42 Million | ▲ +4.6% |
| 2020 | $304.71 Million | $328.01 Million | $23.29 Million | ▲ +74.8% |
| 2019 | $174.35 Million | $178.61 Million | $4.26 Million | ▲ +1532.3% |
| 2018 | $-12.17 Million | $33.46 Million | $45.63 Million | — |